Evidence map›Paper›PMID 42797612›Full record

ArticleVaccines2026

Intranasal Adenoviral Vector Vaccination Induces Durable Antibody and T Cell Responses in the Respiratory Tract.

Woochan Lee, Junghwa Lee, Sun Min Lee, Eui Ho Kim

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Woochan LeeDepartment of Advanced Drug Discovery & Development, University of Science and Technology (UST), Daejeon 34113, Republic of Korea.
Junghwa LeeViral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea.
Sun Min LeeViral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea.ORCID 0000-0002-8438-3365
Eui Ho KimDepartment of Advanced Drug Discovery & Development, University of Science and Technology (UST), Daejeon 34113, Republic of Korea.ORCID 0000-0002-4235-5622

Funding

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
National Research Foundation of Korea NRF-2021R1C1C1012962National Research Foundation of Korea RS-2024-00398073National Research Foundation of Korea RS-2024-00439160NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIDA NIH HHS 75N95020D00005NIH HHS 75N93023D00005NIH HHS 75N99020D00005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adenoviral vectorintranasal vaccinationmucosal immunityrespiratory pathogen

Identifiers

PMID42797612
PMCPMC13611307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.